These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12619548)

  • 1. New therapies for locoregionally advanced and locoregionally recurrent head and neck cancer.
    Wenig BL
    Cancer Treat Res; 2003; 114():315-30. PubMed ID: 12619548
    [No Abstract]   [Full Text] [Related]  

  • 2. Current role of gene therapy in head and neck cancer.
    Ganly I; Soutar DS; Kaye SB
    Eur J Surg Oncol; 2000 Jun; 26(4):338-43. PubMed ID: 10873352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preliminary experience in salvage treatment for advanced recurrent cancers of the head and neck].
    Jiang PJ; Xu ZG
    Zhonghua Zhong Liu Za Zhi; 1991 Jan; 13(1):58-60. PubMed ID: 1889340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological treatment options for locoregionally advanced head and neck squamous cell carcinoma.
    Schutt C; Bumm K; Mirandola L; Bernardini G; Cunha N; Tijani L; Nguyen D; Cordero J; Jenkins MR; Cobos E; Kast WM; Chiriva-Internati M
    Int Rev Immunol; 2012 Feb; 31(1):22-42. PubMed ID: 22251006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of results in neck node metastases from tumors of the head and neck.
    Arcangeli G
    Recent Results Cancer Res; 1988; 107():118-22. PubMed ID: 3131851
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperthermia as an adjuvant to radiation- and/or chemotherapy in far advanced recurrences of the head and neck region.
    Steindorfer P; Jakse R; Germann R; Schneider G; Berger A; Mischinger HJ; Rehak P
    Strahlenther Onkol; 1987 Jul; 163(7):449-52. PubMed ID: 2441480
    [No Abstract]   [Full Text] [Related]  

  • 7. On the relation between improved loco-regional control and disease-free survival in head-and-neck cancer.
    Håkansson K; Rasmussen JH; Bentzen SM; Friborg J; Specht L; Vogelius IR
    Acta Oncol; 2019 Mar; 58(3):390-392. PubMed ID: 30764696
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical trials, referral resource. Treatment of advanced or recurrent squamous cell carcinoma of the head and neck.
    Conley BA; Gore-Langton RE; Cheson BD
    Oncology (Williston Park); 2000 Apr; 14(4):553-4, 559, 561. PubMed ID: 10826315
    [No Abstract]   [Full Text] [Related]  

  • 9. Squamous cell carcinoma of the head and neck: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    ; Pivot X; Villanueva C
    Ann Oncol; 2007 Apr; 18 Suppl 2():ii65-6. PubMed ID: 17491053
    [No Abstract]   [Full Text] [Related]  

  • 10. Decision making in the management of recurrent head and neck cancer.
    Ho AS; Kraus DH; Ganly I; Lee NY; Shah JP; Morris LG
    Head Neck; 2014 Jan; 36(1):144-51. PubMed ID: 23471843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent squamous-cell carcinoma of the head and neck: overview of current therapy and future prospects.
    Ganly I; Kaye SB
    Ann Oncol; 2000 Jan; 11(1):11-6. PubMed ID: 10690381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of head and neck metastatic and/or recurrent cancer by local administration of multi-cytokine inducer OK-432.
    Kitahara S; Ikeda M; Inouye T; Matsunaga T; Yamaguchi K; Takayama E; Healy GB; Tsukuda M
    J Laryngol Otol; 1996 May; 110(5):449-53. PubMed ID: 8762314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successes and Failures of Combined Modality Therapies in Head and Neck Cancer.
    Bowles DW; Deutsch E; Raben D
    Semin Radiat Oncol; 2016 Oct; 26(4):299-306. PubMed ID: 27619251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Head and neck carcinomas.
    Droughton ML
    J Palliat Care; 1990; 6(4):43-6. PubMed ID: 1704913
    [No Abstract]   [Full Text] [Related]  

  • 15. Expanding role of the medical oncologist in the management of head and neck cancer.
    Choong N; Vokes E
    CA Cancer J Clin; 2008; 58(1):32-53. PubMed ID: 18096865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecularly targeted agents and immunotherapy for the treatment of head and neck squamous cell cancer (HNSCC).
    Azoury SC; Gilmore RC; Shukla V
    Discov Med; 2016 Jun; 21(118):507-16. PubMed ID: 27448787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer.
    Frank DK; Hu KS; Culliney BE; Persky MS; Nussbaum M; Schantz SP; Malamud SC; Holliday RA; Khorsandi AS; Sessions RB; Harrison LB
    Laryngoscope; 2005 Jun; 115(6):1015-20. PubMed ID: 15933512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The community approach to salvage therapy for advanced head and neck cancer.
    Adelstein DJ
    Semin Oncol; 1994 Aug; 21(4 Suppl 7):52-7. PubMed ID: 7522350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of the neck in head and neck mucosal squamous cell carcinoma: what our experience teaches.
    Marcial VA; Marcial-Vega VA
    Front Radiat Ther Oncol; 1994; 28():51-65. PubMed ID: 7982604
    [No Abstract]   [Full Text] [Related]  

  • 20. Single-arm phase II study of multiagent concurrent chemoradiotherapy and gefitinib in locoregionally advanced squamous cell carcinoma of the head and neck.
    Rodriguez CP; Adelstein DJ; Rybicki LA; Saxton JP; Lorenz RR; Wood BG; Scharpf J; Ives DI
    Head Neck; 2012 Nov; 34(11):1517-23. PubMed ID: 22180262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.